In the above mentioned study, in the patients that did not develop GVHD, not only the NCR+ ILC3, but all circulating ILC subsets expressed high levels of the activation marker CD69 and either skin‐ or gut‐homing integrin molecules 10. This evidence concerns the gene CCL27 and graft versus host disease.